BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26955)

  • 1. [Antibiotic therapy of Pseudomonas aeruginosa infections: possibilities and limitations].
    Voiculescu M; Golăescu M; Giuglea M; Mătuşa R; Alexandru S
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1978; 30(2):157-64. PubMed ID: 26955
    [No Abstract]   [Full Text] [Related]  

  • 2. Antimicrobial susceptibility of gentamicin-resistant Pseudomonas aeruginosa.
    Yu PK; Washington JA
    Mayo Clin Proc; 1977 Dec; 52(12):802-5. PubMed ID: 413013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro effects of the combination of carbenicillin with gentamicin or tobramycin with respect to Pseudomonas aeruginosa].
    Turgeon PL; Croteau L
    Union Med Can; 1977 May; 106(5):682-5. PubMed ID: 405784
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bacteriological studies on the therapy of bacillus pyocyaneus infections].
    Metz H; Ohgke H; Hartmann I
    Int J Clin Pharmacol Biopharm; 1975 Oct; 12(3):342-8. PubMed ID: 809372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics.
    Ramírez-Ronda CH; Nevárez M; Gutiérrez-Núñez JJ; Reyes Y
    Bol Asoc Med P R; 1983 Jul; 75(7):305-7. PubMed ID: 6442865
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tobramycin: comparison with gentamicin and carbenicillin in regard to 200 serotyped strains of Pseudomonas aeruginosa].
    Turgeon PL
    Union Med Can; 1977 Jan; 106(1):46-50. PubMed ID: 403645
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative study of the effect of sisomicin and other aminoglycosides on the causative agents of surgical infection].
    Navashin PS
    Antibiotiki; 1982 Dec; 27(12):26-9. PubMed ID: 6819812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ["In vitro" activity of gentamicin, sisomicin and tobramycin against "pseudomonas aeruginosa" strains from hospital sources (author's transl)].
    Campello C; Crevatin E
    Ann Sclavo; 1977; 19(3):437-45. PubMed ID: 415672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serological typing of strains of Pseudomonas aeruginosa. II. Correlations between the O-serotype and sensitivity to 3 aminoglycosides (tobramycin, gentamicin and sisomicin)].
    Berti P; Maranini B; Mazzoni P
    Ann Sclavo; 1980; 22(4):709-16. PubMed ID: 6787999
    [No Abstract]   [Full Text] [Related]  

  • 10. In-vitro comparison of four antipseudomonal antibiotics in a general hospital.
    Khan AJ; Evans HE; Cherubin CE; Hochstein L
    Curr Ther Res Clin Exp; 1976 Apr; 19(4):479-82. PubMed ID: 816606
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro bacteriological study of a new antibiotic substance: sisomicin.
    Jedlicková Z; Sulová J
    Zentralbl Bakteriol Orig A; 1975 Jan; 230(1):104-11. PubMed ID: 809943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of tobramycin and gentamicin against Enterobacteriaceae and gentamicin-resistant, carbenicillin-resistant Pseudomonas aeruginosa.
    Watanakunakorn C; Bannister T
    Curr Ther Res Clin Exp; 1975 May; 17(5):488-96. PubMed ID: 805033
    [No Abstract]   [Full Text] [Related]  

  • 13. Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center.
    Ciofu O; Giwercman B; Pedersen SS; Høiby N
    APMIS; 1994 Sep; 102(9):674-80. PubMed ID: 7946270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sisomicin: an aminoglycoside antibiotic that is highly effective against Pseudomonas.
    Sanders WE; Sanders CC
    J Int Med Res; 1981; 9(3):168-76. PubMed ID: 6786934
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative in vitro activity of tobramycin, gentamicin, kanamycin, colistin, carbenicillin, and ticarcillin and clinical isolates of Pseudomonas aeruginosa: epidemiological and therapeutic implications.
    Dulong de Rosnay HL; Grimont PA; Dessaut B; Lesgouarres MT
    J Infect Dis; 1976 Aug; 134 Suppl():S50-6. PubMed ID: 823279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibacterial activity of gentamicin, tobramycin, amikacin, and sisomicin in vitro (author's transl)].
    Skalova R; Hajsig D; Babić I; Mostovac D
    Lijec Vjesn; 1978 Nov; 100(11):708-10. PubMed ID: 107386
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro evaluation of cefoperazone compared to other antipseudomonal drugs.
    Nicoletti P; Mazzei T; Lamanna S
    G Batteriol Virol Immunol; 1981; 74(1-6):3-7. PubMed ID: 6458526
    [No Abstract]   [Full Text] [Related]  

  • 18. Activity of amikacin, gentamicin and tobramycin combined with carbenicillin or ticarcillin against Pseudomonas aeruginosa in vitro.
    Meitert E; Petrescu AM; Chiru M
    Arch Roum Pathol Exp Microbiol; 1985; 44(2):127-36. PubMed ID: 3938268
    [No Abstract]   [Full Text] [Related]  

  • 19. [Susceptibility of Pseudomonas aeruginosa to gentamicin, carbenicillin and framycetin].
    Abdou MA
    Arzneimittelforschung; 1973 Jun; 23(6):785-91. PubMed ID: 4199200
    [No Abstract]   [Full Text] [Related]  

  • 20. Routine susceptibility tests with ticarcillin and tobramycin in combination should be more appropriate than with each antibiotic alone in cystic fibrosis Pseudomonas aeruginosa.
    Lapointe JR; Bourget C; Mainville S; Lafleur L; Lagacé J; Montplaisir S
    J Chemother; 1989 Jul; 1(4 Suppl):184-6. PubMed ID: 16312360
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.